Trading window closure ahead of Q2 results

Compliance View source PDF Explain this filing

ANTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.1%Reaction day

₹885.00

prior close

₹888.00

announcement price

After-mkt

timing

Nifty Midcap 150market-0.1%-1.0% vs market

Pharmaceuticals & Biotechnology peers, median of 176sector · industry level-0.0%-1.1% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Midcap 150 and 1.1 pts less than its Pharmaceuticals & Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.0

15m

-0.1

30m

-0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.1-0.1-1.0-0.0-1.1

Next day

-3.4-1.8-1.6-1.3-2.1

-1.1-2.7+1.7-0.5-0.6

-3.1-2.7-0.4-1.6-1.5

-3.0-3.7+0.7-2.5-0.5

-3.9-3.2-0.7-2.7-1.2

+0.2-2.8+3.0-2.2+2.5

15d

-9.2-4.3-4.9-6.1-3.1

-7.1-7.4+0.3-9.3+2.3

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals & Biotechnology peers, median of 176Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anthem Biosciences has informed the exchanges that the trading window for dealing in its shares will be closed for all designated persons from October 1, 2026 until 48 hours after the Board meeting that approves financial results for the quarter and half year ending September 30, 2026. Designated persons have been asked not to trade during this period, as required under SEBI insider trading rules. The Board meeting date will be announced later.

Likely market impact

Routine compliance filing. Indicates Q2 and H1 FY26 results are due soon; no material impact on the stock expected.